Patent · US Active

Combination therapy for proliferative disorders

US9486445B2 · kind B2 · utility

10Cited by

7References

15Claims

0Family size

Assignee

Hoffmann-La Roche Inc. · US

Inventors

Brian Higgins · Dayton, US
Kenneth Kolinsky · Bloomingdale, US
Gwen Nichols · New York, US
Kathryn Packman · Newton, US
Fei Su · Wang'an Town, TW

Key dates

Filing date	Jul 22, 2015
Grant date	Nov 8, 2016
Priority date	—
Expiry date	Jul 22, 2035

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Treatment of proliferative diseases with a combination of a b-Raf inhibitor and MDM2 inhibitor.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.